Followers | 227 |
Posts | 13151 |
Boards Moderated | 0 |
Alias Born | 09/26/2011 |
Monday, November 28, 2022 3:54:48 PM
Recent NUWE News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/17/2024 09:22:31 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 05/17/2024 09:20:53 PM
- Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida • GlobeNewswire Inc. • 05/14/2024 01:00:00 PM
- Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy • GlobeNewswire Inc. • 05/09/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 09:28:54 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 05/08/2024 09:26:11 PM
- Nuwellis, Inc. Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology • GlobeNewswire Inc. • 05/02/2024 01:00:00 PM
- Nuwellis Announces Closing of $2.7 Million Public Offering • GlobeNewswire Inc. • 04/30/2024 10:09:12 PM
- Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/30/2024 08:41:07 PM
- Nuwellis Announces Pricing of $2.7 Million Public Offering • GlobeNewswire Inc. • 04/26/2024 01:17:51 PM
- Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health • GlobeNewswire Inc. • 04/09/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 09:08:24 PM
- Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 03/07/2024 02:08:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 05:02:05 PM
- Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- U.S. Futures Dip, Crude Oil Fluctuates • IH Market News • 03/05/2024 11:05:54 AM
- Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 • GlobeNewswire Inc. • 02/27/2024 02:00:00 PM
- Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™ • GlobeNewswire Inc. • 02/22/2024 12:58:00 PM
- Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/20/2024 10:06:53 PM
- Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 02/20/2024 01:42:52 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/08/2024 10:19:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:07:29 PM
- New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/09/2024 10:30:52 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM